1. Discordance between PAM50 intrinsic subtyping and immunohistochemistry in South African women with breast cancer

   • Thérèse Dix-Peek
   • Boitumelo P. Phakathi
   • Raquel A. B. Duarte

   Preclinical study Open access 03 March 2023 Pages: 1 - 12

   

2. Antitumor activity of the PI3K δ-sparing inhibitor MEN1611 in PIK3CA mutated, trastuzumab-resistant HER2 + breast cancer

   • Alessio Fiascarelli
   • Giuseppe Merlino
   • Monica Binaschi

   Preclinical study Open access 13 March 2023 Pages: 13 - 23

   

3. Impact of multifocal or multicentric disease on local recurrence and survival in breast cancer patients with or without BRCA1/2 variants

   • Xuejing Liu
   • Yanjie Wang
   • Yuntao Xie

   Preclinical study 17 March 2023 Pages: 25 - 33

   

4. Aromatase inhibition plus/minus Src inhibitor saracatinib (AZD0530) in advanced breast cancer therapy (ARISTACAT): a randomised phase II study

   • Ailsa J. Oswald
   • Stefan N. Symeonides
   • David A. Cameron

   Clinical trial Open access 02 March 2023 Pages: 35 - 46

   

5. Neoadjuvant pegylated liposomal doxorubicin- and epirubicin-based combination therapy regimens for early breast cancer: a multicenter retrospective case–control study

   • Jui-Hung Tsai
   • Chung-Liang Li
   • Yao-Lung Kuo

   Clinical trial 04 March 2023 Pages: 47 - 55

   

6. A prediction model for distant metastasis after isolated locoregional recurrence of breast cancer

   • Takeshi Murata
   • Masayuki Yoshida
   • Akihiko Suto

   Clinical trial Open access 04 March 2023 Pages: 57 - 66

   

7. Pegylated liposomal doxorubicin (Duomeisu^®) monotherapy in patients with HER2-negative metastatic breast cancer heavily pretreated with anthracycline and taxanes: a single-arm, phase II study

   • Hanfang Jiang
   • Huiping Li
   • Huan Wang

   Clinical trial Open access 06 March 2023 Pages: 67 - 79

   

8. De-ESCAlating RadioTherapy in breast cancer patients with pathologic complete response to neoadjuvant systemic therapy: DESCARTES study

   • Annemiek K. E. van Hemert
   • Josefien P. van Olmen
   • Frederieke H. van Duijnhoven

   Clinical trial 09 March 2023 Pages: 81 - 89

   

9. Using Oncotype DX breast recurrence score® assay to define the role of neoadjuvant endocrine therapy in early-stage hormone receptor-positive breast cancer

   • Caitlin Taylor
   • Jane Meisel
   • Ruth O’Regan

   Clinical trial Open access 10 March 2023 Pages: 91 - 98

   

10. Impact of prior systemic therapy on lymphocytic infiltration in surgically resected breast cancer brain metastases

    • S. Chew Minmin
    • A. Bacotti
    • A. D. Seidman

    Clinical trial 17 March 2023 Pages: 99 - 107

    

11. The effects of exercise and diet on oxidative stress and telomere length in breast cancer survivors

    • Justin C. Brown
    • Kathleen Sturgeon
    • Kathryn H. Schmitz

    Clinical trial 18 March 2023 Pages: 109 - 117

12. Does a brief surgeon training in negotiation theory principles decrease rates of contralateral prophylactic mastectomy?

    • Anita Mamtani
    • Daniel D. Sjoberg
    • Monica Morrow

    Epidemiology 07 March 2023 Pages: 119 - 126

    

13. BRCA1 and BRCA2 germline mutation analysis from a cohort of 1267 patients at high risk for breast cancer in Brazil

    • Patricia Mazzonetto
    • Fernanda Milanezi
    • Ilana Zalcberg

    Epidemiology 07 March 2023 Pages: 127 - 136

    

14. mTOR pathway candidate genes and physical activity interaction on breast cancer risk in black women from the women’s circle of health study

    • Mmadili N. Ilozumba
    • Lusine Yaghjyan
    • Ting-Yuan David Cheng

    Epidemiology 08 March 2023 Pages: 137 - 146

15. Reproducibility and intratumoral heterogeneity of the PAM50 breast cancer assay

    • Amber N. Hurson
    • Alina M. Hamilton
    • Melissa A. Troester

    Epidemiology Open access 09 March 2023 Pages: 147 - 154

    

16. Treatment-related side effects among Hispanic and non-Hispanic white long-term breast cancer survivors by tamoxifen use and duration

    • Kate E. Dibble
    • Richard N. Baumgartner
    • Avonne E. Connor

    Epidemiology 09 March 2023 Pages: 155 - 172

17. Implications for surveillance for breast cancer patients based on the internally and externally validated BRENDA-metastatic recurrence score

    • Florian Ebner
    • Jessica Salmen
    • Manfred Wischnewsky

    Epidemiology Open access 14 March 2023 Pages: 173 - 184

    

18. History of infertility and risk of breast cancer: a prospective cohort study

    • Leslie V. Farland
    • Siwen Wang
    • Stacey A. Missmer

    Epidemiology 16 March 2023 Pages: 185 - 193

19. Post-diagnostic statin use and breast cancer-specific mortality: a population-based cohort study

    • Oliver William Scott
    • Sandar TinTin
    • J. Mark Elwood

    Epidemiology Open access 17 March 2023 Pages: 195 - 206

20. Adaptive immune receptor features related to breast cancer tissue in Kenyan patients: high immunoglobulin gene expression and high levels of gamma-delta T-cells

    • Kennedy W. Mwangi
    • Moses K. Kamita
    • Francis W. Makokha

    Original Laboratory Investigation 08 March 2023 Pages: 207 - 214